Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Richard Vosser's Stock Ratings
JP Morgan Analyst
Richard Vosser is an analyst at JP Morgan. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 05/21/2025
Overall Average Return
-1.81%
Smart Score
Overall Average Return Percentile
33rd
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 12/05/2023 | MOR | Buy Now | MorphoSys | — | — | Richard Vosser44% | $10 → $8.5 | Maintains | Overweight | Get Alert |
| 12/05/2023 | MOLN | Buy Now | Molecular Partners | $3.94 | 14.21% | Richard Vosser44% | $6.6 → $4.5 | Maintains | Neutral | Get Alert |
| 06/16/2023 | MOR | Buy Now | MorphoSys | — | — | Richard Vosser44% | $3.3 → $10 | Upgrade | Underweight → Overweight | Get Alert |
| 01/03/2023 | MOR | Buy Now | MorphoSys | — | — | Richard Vosser44% | — | Downgrade | Neutral → Underweight | Get Alert |
| 06/07/2022 | NVO | Buy Now | Novo Nordisk | $69.40 | — | Richard Vosser44% | — | Upgrade | Neutral → Overweight | Get Alert |
| 12/20/2021 | NVO | Buy Now | Novo Nordisk | $69.40 | — | Richard Vosser44% | — | Downgrade | Overweight → Neutral | Get Alert |
| 09/02/2021 | UCBJY | Buy Now | UCB | $92.71 | — | Richard Vosser44% | — | Upgrade | Neutral → Overweight | Get Alert |
| 02/23/2021 | LZAGY | Buy Now | Lonza Group | $68.37 | — | Richard Vosser44% | — | Upgrade | Neutral → Overweight | Get Alert |
| 01/06/2020 | SNY | Buy Now | Sanofi | $53.33 | — | Richard Vosser44% | — | Upgrade | Neutral → Overweight | Get Alert |
| 11/19/2018 | NVO | Buy Now | Novo Nordisk | $69.40 | — | Richard Vosser44% | — | Upgrade | Neutral → Overweight | Get Alert |
| 12/29/2017 | NVO | Buy Now | Novo Nordisk | $69.40 | — | Richard Vosser44% | — | Upgrade | Underweight → Neutral | Get Alert |
| 09/09/2016 | NVO | Buy Now | Novo Nordisk | $69.40 | — | Richard Vosser44% | — | Downgrade | Outperform → Neutral | Get Alert |
| 02/24/2014 | NVO | Buy Now | Novo Nordisk | $69.40 | — | Richard Vosser44% | — | Upgrade | Underweight → Overweight | Get Alert |
| 01/06/2014 | SNY | Buy Now | Sanofi | $53.33 | — | Richard Vosser44% | — | Downgrade | Overweight → Neutral | Get Alert |
| 03/18/2013 | NVO | Buy Now | Novo Nordisk | $69.40 | — | Richard Vosser44% | — | Downgrade | Neutral → Underweight | Get Alert |
